SCHEMBL19341747

SCHEMBL19341747

CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)C(CC#N)NC(=O)c1cc(CN2CCOCC2)on1)C(=O)[C@@]1(C)CO1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTRL P40313 11/20 0.83
▸ TMPRSS11D O60235 5/20 0.83
▸ PSMB5 P28074 8/20 0.59
▸ PSMB9 P28065 2/20 0.59
▸ PSMB11 A5LHX3 1/20 0.59
▸ PSMD11 O00231 1/20 0.59
▸ PSMD12 O00232 1/20 0.59
▸ PSMD14 O00487 1/20 0.59
▸ PSMA7 O14818 1/20 0.59
▸ PSMD3 O43242 1/20 0.59
▸ CTSB P07858 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ PSMC3 P17980 1/20 0.59
▸ PSMB1 P20618 1/20 0.59
▸ CYP3A5 P20815 1/20 0.59
▸ CYP3A7 P24462 1/20 0.59
▸ PSMA1 P25786 1/20 0.59
▸ PSMA2 P25787 1/20 0.59
▸ PSMA3 P25788 1/20 0.59
▸ PSMA4 P25789 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14964430 1.00 CTRL (0.83) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL8141331 1.00 CTRL (0.83) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL19289573 1.00 CTRL (0.83) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL14900025 0.94 CTRL (0.90) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL19289605 0.94 CTRL (0.90) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL22423754 0.94 CTRL (0.90) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL8135868 0.94 CTRL (0.90) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL8123039 0.94 CTRL (0.90) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL8122776 0.92 CTRL (0.71) CTRLTMPRSS11DPSMB5PSMB9PSMB11
SCHEMBL19289275 0.92 CTRL (0.87) CTRLTMPRSS11DPSMB5PSMB9PSMB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170260230-A1 COMPUNDS FOR ENZYME INHIBITION ONYX THERAPEUTICS INC (US) 2017-09-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260230-A1 COMPUNDS FOR ENZYME INHIBITION ANPEP, PSMB1, CPN1 CTRL 26/4885TMPRSS11D 307/4885PSMB5 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback